Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine Plus Carboplatin in Platinum-Resistant Ovarian Cancer
NCT03467178Phase 2Unknown
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jul 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in ovarian cancer, sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Status: unknown.
02
Drugs
decitabine
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03467178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03467178.